Key Takeaways for Clinicians from the KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, & Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
This is the first guideline from KDIGO on a rare kidney disease, and provides healthcare providers, stakeholders, and people living with ADPKD with practical tools to improve diagnosis, care, and treatment, and address the complex challenges of managing this genetic kidney disorder.1
Dr. Torres is the work group co-chair and Dr. Harris and Dr. Chapman are working group members involved in developing the guidelines. These guidelines span topics such as disease nomenclature, diagnosis, prognosis, kidney and extrarenal manifestations, treatment strategies, and …
